Action PharmaTher - PHRM

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,20

Prix Achat

0,20

Prix Vente

0,22

Volume échangé

2 777

0,195 Fourchette du Jour 0,20

0,17 Plage de 52 semaines 0,43

Clôture Veille

0,205

Ouverture

0,195

Dernière Transaction

500

0.2

Dernière heure de transaction

Volume moyen (3 m)

59 340

Volume financier

VWAP

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Delivering psilocybin via microneedle patch unlocks potential for...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch Focusing on...

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO to manufacture...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving its second FDA orphan drug...

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund TORONTO, September 21, 2021 -- InvestorsHub...

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022 10 clinical sites...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Focusing on becoming a global leader in...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Strengthens position to...

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Potential...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease TORONTO, May 25, 2021...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.01	-4.7619047619	0.21	0.215	0.195	82645	0.20435112	CS
4	-0.01	-4.7619047619	0.21	0.23	0.195	45396	0.20997862	CS
12	-0.015	-6.97674418605	0.215	0.28	0.19	59340	0.22476957	CS
26	-0.01	-4.7619047619	0.21	0.33	0.18	82424	0.23669506	CS
52	-0.015	-6.97674418605	0.215	0.43	0.17	83474	0.24580902	CS
156	-0.05	-20	0.25	0.43	0.055	98396	0.18278377	CS
260	-0.055	-21.568627451	0.255	1.24	0.05	196372	0.34752916	CS

PHRM - Frequently Asked Questions (FAQ)

What is the current PharmaTher share price?

The current share price of PharmaTher is $ 0,20

What is the 1 year trading range for PharmaTher share price?

PharmaTher has traded in the range of $ 0,17 to $ 0,43 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MJRXGlobal Health Clinics Ltd	$ 0,02 (100,00%)	1 000
BLRBlackhawk Growth Corp	$ 0,01 (100,00%)	14k
GRUVProtium Clean Energy Corp	$ 0,035 (75,00%)	3,27M
ADPAdelphi Metals Inc	$ 0,20 (73,91%)	2,02k
GRHKGreenhawk Resources Inc	$ 0,025 (66,67%)	2,09M
WBGDWaraba Gold Limited	$ 0,005 (-50,00%)	9k
CVGRCity View Green Holdings Inc	$ 0,005 (-50,00%)	51k
CATCAT Strategic Metals Corporation	$ 0,005 (-50,00%)	52k
ASTIAquarius Surgical Technologies Inc	$ 0,01 (-50,00%)	36k
URMFirst American Uranium Inc	$ 0,015 (-40,00%)	6,84k
QIMCQuebec Innovative Materials Corp	$ 0,23 (35,29%)	6,87M
AIMLAl ML Innovations Inc	$ 0,06 (-14,29%)	3,84M
GRUVProtium Clean Energy Corp	$ 0,035 (75,00%)	3,27M
GRHKGreenhawk Resources Inc	$ 0,025 (66,67%)	2,09M
SANUSanu Gold Corp	$ 0,255 (8,51%)	1,9M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

PharmaTher Holdings Ltd (PHRM)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

PHRM Dernières nouvelles

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

PHRM - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

PharmaTher Holdings Ltd (PHRM) Cours

PharmaTher Holdings Ltd (PHRM)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

PHRM Dernières nouvelles

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

PHRM - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités